Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biju Mohamed

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Age and Ageing|September 12, 2021
Feasibility of remote Memory Clinics using the plan, do, study, act (PDSA) cycleJemima T Collins, Biju Mohamed, Antony Bayer
BMJ Open Quality|September 22, 2020
Using telemedicine and wearable technology to establish a virtual clinic for people with Parkinson's diseaseLauren Evans, Biju Mohamed, Edward Christopher Thomas
Therapeutic Advances in Neurological Disorders|December 11, 2019
The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)Francesca Morgante, Ganesh Bavikatte, Fahim Anwar, et al.
Journal of Medical Economics|November 29, 2018
Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and WalesSvetlana Kalabina, Jonathan Belsey, Dominic Pivonka, et al.
Clinical Gerontologist|September 5, 2023
CBT for Generalized Anxiety Disorder in Parkinson's Disease: A Case StudyAlina Elena Apostol, Biju Mohamed, Christopher Thomas, et al.
Neurodegenerative Disease Management|July 6, 2018
Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialistsRobin Fackrell, Camille B Carroll, Donald G Grosset, et al.
Journal of Parkinson'S Disease|January 13, 2024
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert PanelCamille Carroll, Carl E Clarke, Donald Grosset, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Aberrant CD4 <sup>+</sup> T cell refeeding response impairs neuro-immune crosstalk in Parkinson's diseaseKarl Austin-Muttitt, Bethan R David, Martina Sassi, et al.
Movement Disorders Clinical Practice|May 2, 2024
Improving Conversations about Parkinson's DementiaIvelina Dobreva, Joanne Thomas, Anne Marr, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Age and Ageing|September 12, 2021
Feasibility of remote Memory Clinics using the plan, do, study, act (PDSA) cycleJemima T Collins, Biju Mohamed, Antony Bayer
BMJ Open Quality|September 22, 2020
Using telemedicine and wearable technology to establish a virtual clinic for people with Parkinson's diseaseLauren Evans, Biju Mohamed, Edward Christopher Thomas
Therapeutic Advances in Neurological Disorders|December 11, 2019
The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)Francesca Morgante, Ganesh Bavikatte, Fahim Anwar, et al.
Journal of Medical Economics|November 29, 2018
Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and WalesSvetlana Kalabina, Jonathan Belsey, Dominic Pivonka, et al.
Clinical Gerontologist|September 5, 2023
CBT for Generalized Anxiety Disorder in Parkinson's Disease: A Case StudyAlina Elena Apostol, Biju Mohamed, Christopher Thomas, et al.
Neurodegenerative Disease Management|July 6, 2018
Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialistsRobin Fackrell, Camille B Carroll, Donald G Grosset, et al.
Journal of Parkinson'S Disease|January 13, 2024
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert PanelCamille Carroll, Carl E Clarke, Donald Grosset, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Aberrant CD4 <sup>+</sup> T cell refeeding response impairs neuro-immune crosstalk in Parkinson's diseaseKarl Austin-Muttitt, Bethan R David, Martina Sassi, et al.
Movement Disorders Clinical Practice|May 2, 2024
Improving Conversations about Parkinson's DementiaIvelina Dobreva, Joanne Thomas, Anne Marr, et al.
Pageof 1